Treatments prohibited within 7 days of starting the study | |
---|---|
● Any antibiotic | ● Topical corticosteroids |
● Drugs interfering with CsA such as ketoconazole, itraconazole, miconazole, phenobarbital. | |
Treatments prohibited within 14 days of starting the study | |
● Cylosporine A | ● Systemic short acting glucocorticosteroids, including ophthalmic and otic preparations |
● Antihistamines | ● Non-steroidal anti-inflammatory drugs (NSAIDs) |
● Topical calcineurin inhibitors | ● Shampoos (except where the same treatment regimen is maintained throughout the study). |
● Vaccination | ● Clomipramine, amitriptyline and fluoxetine and any other serotonin reuptake inhibitor |
Other prohibited treatments | |
● Allergen specific immunotherapy (except if initiated for at least 9 months and where the same treatment regimen is maintained throughout the study). | |
● Treatment with systemic long-acting corticosteroids within the last 3 months | |
● Essential fatty acids except those used before study initiation for at least 57 days and where the same treatment regime is maintained throughout the study |